Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundingYear |
|
| dbo:industry | |
| dbo:locationCity | |
| dbo:thumbnail | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink |
|
| dbp:hqLocationCity | |
| dbp:industry | |
| dbp:logo |
|
| dbp:name |
|
| dbp:products |
|
| dbp:tradedAs |
|
| dbp:type |
|
| dbp:website | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| skos:closeMatch | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:institution of | |
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |
